Clinical trial Recruiting at 1 site Interventional Ages 40 and up

Using magnetic stimulation to improve motor symptoms in Parkinson's disease

Official title: A Randomized, Double-blind, Multicenter, Placebo-controlled Trial (PRESS-PD)

Run by Anhui Medical University · NCT06383247 · Data updated 2026-11-12

This study is testing if a new brain stimulation technique can help improve movement problems in people with Parkinson's disease.

Quick facts

Study typeInterventional
Ages40 Years and up
SexAll
Enrollment290 (estimated)
SponsorAnhui Medical University
Academic / other
Locations1 site (Hefei, Anhui)
StatusRecruiting
StartedDecember 6, 2024
Main results expectedDecember 31, 2026
Study endsDecember 31, 2028
Registry record updatedJune 17, 2025
Trial IDNCT06383247 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 40 and older diagnosed with idiopathic Parkinson's disease who meet specific clinical criteria.

Probably not a fit

Patients with secondary parkinsonism syndromes or those with severe brain injuries or implants that are incompatible with magnetic stimulation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the efficacy and safety of repetitive transcranial magnetic stimulation (rTMS) in alleviating motor symptoms in patients with Parkinson's disease. It is a multi-center, double-blind, randomized controlled trial conducted across various hospital centers in China. The study focuses on stimulating the supplementary motor area of the brain using a specific stimulation protocol over a course of 7 days, with the aim of observing changes in clinical symptoms before and after the intervention.

Why it matters

Potential benefit: If successful, this treatment could significantly improve motor symptoms and potentially delay the progression of Parkinson's disease.

How similar studies have gone: Previous small sample studies have shown promising results for rTMS in treating Parkinson's disease, suggesting potential for success in this larger trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 40 years old;
2. Meet the diagnostic criteria for idiopathic Parkinson's disease (MDS Diagnostic Criteria for Parkinson's Disease (2015 Edition))\[1\];
3. Have no history of drug adjustment within 4 weeks before treatment and the entire study period;
4. The MDS-UPDRS Ⅲ score ≥8, and the Hoehn-Yahr rating is 1-4;
5. MMSE ≥22,able to cooperate with the completion of behavioral tests and transcranial magnetic stimulation therapy.

Exclusion Criteria:

1. Previously head MRI/CT was focal brain injury or severe leukoencephalopathy (Fazekas grade 3 and above);
2. Various secondary parkinsonism syndromes (vascular parkinsonism, Parkinsonism combined with parkinsonism, drug parkinsonism, etc.);
3. Severe craniocerebral trauma, received craniocerebral surgery or deep brain stimulation treatment;
4. There are ferromagnetic implants in the body, such as cochlear implants, cardiac pacemakers, etc.
5. The person has a history of epilepsy, unexplained loss of consciousness, or are taking anticonvulsant drugs to treat epileptic seizures;
6. Diagnosed with a neuropsychiatric disorder other than PD
7. Have a history of drug abuse or drug use;
8. Participants in any clinical trial within the previous 6 month;
9. Pregnant/lactating women or subjects (including men) who have a birth plan within 6 months;
10. Other conditions deemed unsuitable for inclusion by the investigator.

Where it's running

  • Cognitive Neuropsychology Lab Anhui Medical University
    Hefei, Anhui, China
    Recruiting

Study contacts

  • Principal investigator: Panpan Hu, M.D. — The First Affiliated Hospital of Anhui Medical University
  • Study coordinator: Panpan Hu, M.D.
  • Email: hpppanda9@126.com
  • Phone: +8613515602285

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.